{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:17:48Z","timestamp":1792592268555,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:00:00Z","timestamp":1723334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:00:00Z","timestamp":1723334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["JPMH23FC1026"],"award-info":[{"award-number":["JPMH23FC1026"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12072-024-10714-1","type":"journal-article","created":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T13:02:01Z","timestamp":1723381321000},"page":"1385-1395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Acute presentation of autoimmune hepatitis \u2013from acute hepatitis to ALF and ACLF-"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6358-5283","authenticated-orcid":false,"given":"Atsushi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,11]]},"reference":[{"key":"10714_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/hepr.13776","volume":"52","author":"H Ohira","year":"2022","unstructured":"Ohira H, et al. Clinical practice guidelines for autoimmune hepatitis. Hepatol Res. 2022;52:571\u2013585","journal-title":"Hepatol Res"},{"key":"10714_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12072-021-10170-1","volume":"15","author":"G Wang","year":"2021","unstructured":"Wang G, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int. 2021;15:223\u2013257","journal-title":"Hepatol Int"},{"key":"10714_CR3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.dld.2018.02.015","volume":"50","author":"P Muratori","year":"2018","unstructured":"Muratori P, et al. Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: an Italian multicentre study. Dig Liver Dis. 2018;50:698\u2013702","journal-title":"Dig Liver Dis"},{"key":"10714_CR4","doi-asserted-by":"publisher","first-page":"3513206","DOI":"10.1155\/2018\/3513206","volume":"2018","author":"Y Shen","year":"2018","unstructured":"Shen Y, et al. Clinical and pathological characteristics of autoimmune hepatitis with acute presentation. Can J Gastroenterol Hepatol. 2018;2018:3513206","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10714_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5114\/ceh.2020.93051","volume":"6","author":"N Sonthalia","year":"2020","unstructured":"Sonthalia N, et al. Clinical, serological, histopathological and treatment profile of autoimmune hepatitis in the elderly. Clin Exp Hepatol. 2020;6:13\u201319","journal-title":"Clin Exp Hepatol"},{"key":"10714_CR6","doi-asserted-by":"publisher","first-page":"14250","DOI":"10.1038\/s41598-020-71296-0","volume":"10","author":"A Takahashi","year":"2020","unstructured":"Takahashi A, et al. Increasing incidence of acute autoimmune hepatitis: a nationwide survey in Japan. Sci Rep. 2020;10:14250","journal-title":"Sci Rep"},{"key":"10714_CR7","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","volume":"58","author":"AJ Czaja","year":"2013","unstructured":"Czaja AJ. Acute and acute severe (fulminant) autoimmune hepatitis. Dig Dis Sci. 2013;58:897\u2013914","journal-title":"Dig Dis Sci"},{"key":"10714_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1872-034X.2011.00810.x","volume":"41","author":"M Onji","year":"2011","unstructured":"Onji M, Autoimmune Hepatitis Study G. Proposal of autoimmune hepatitis presenting with acute hepatitis, severe hepatitis and acute liver failure. Hepatol Res. 2011;41:497","journal-title":"Hepatol Res"},{"key":"10714_CR9","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/lt.25615","volume":"25","author":"GN Dalekos","year":"2019","unstructured":"Dalekos GN, Gatselis NK, Zachou K. Acute severe autoimmune hepatitis: corticosteroids or liver transplantation? Liver Transpl. 2019;25:1588\u20131589","journal-title":"Liver Transpl"},{"key":"10714_CR10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jhep.2014.05.021","volume":"61","author":"AD Yeoman","year":"2014","unstructured":"Yeoman AD, et al. Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome. J Hepatol. 2014;61:876\u2013882","journal-title":"J Hepatol"},{"key":"10714_CR11","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/hep4.1521","volume":"4","author":"A Ikura","year":"2020","unstructured":"Ikura A, et al. CLIF-C organ failure score and liver volume predict prognosis in steroid-treated severe acute autoimmune hepatitis. Hepatol Commun. 2020;4:1019\u20131033","journal-title":"Hepatol Commun"},{"key":"10714_CR12","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.dld.2022.08.035","volume":"54","author":"M Jo\u00e3o","year":"2022","unstructured":"Jo\u00e3o M, et al. Severe acute autoimmune hepatitis: How to early predict who will not respond to corticosteroids and needs urgent liver transplantation? Dig Liver Dis. 2022;54:1681\u20131685","journal-title":"Dig Liver Dis"},{"key":"10714_CR13","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/j.cgh.2021.06.006","volume":"20","author":"F Noguchi","year":"2022","unstructured":"Noguchi F, et al. Early dynamics of MELD scores predict corticosteroid responsiveness to severe acute-onset autoimmune hepatitis. Clin Gastroenterol Hepatol. 2022;20:2641-2643.e2643","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10714_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/apt.16926","volume":"56","author":"L T\u00e9llez","year":"2022","unstructured":"T\u00e9llez L, et al. Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study. Aliment Pharmacol Ther. 2022;56:131\u2013143","journal-title":"Aliment Pharmacol Ther"},{"key":"10714_CR15","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1002\/lt.25906","volume":"26","author":"M Biewenga","year":"2020","unstructured":"Biewenga M, et al. Early predictors of short-term prognosis in acute and acute severe autoimmune hepatitis. Liver Transpl. 2020;26:1573\u20131581","journal-title":"Liver Transpl"},{"key":"10714_CR16","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jhep.2020.12.033","volume":"74","author":"E De Martin","year":"2021","unstructured":"De Martin E, et al. Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: the SURFASA score. J Hepatol. 2021;74:1325\u20131334","journal-title":"J Hepatol"},{"key":"10714_CR17","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/hep.24141","volume":"53","author":"AD Yeoman","year":"2011","unstructured":"Yeoman AD, et al. Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis. Hepatology. 2011;53:926\u2013934","journal-title":"Hepatology"},{"key":"10714_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000487940","volume":"98","author":"OE Anastasiou","year":"2018","unstructured":"Anastasiou OE, et al. Corticosteroid therapy improves the outcome of autoimmune hepatitis-induced acute liver failure. Digestion. 2018;98:104\u2013111","journal-title":"Digestion"},{"key":"10714_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/LVT.0000000000000105","volume":"29","author":"T Enke","year":"2023","unstructured":"Enke T, et al. Autoimmune hepatitis presenting as acute liver failure. A 20-year retrospective review of North America. Liver Transpl. 2023;29:570\u2013580","journal-title":"Liver Transpl"},{"key":"10714_CR20","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/hep.26678","volume":"59","author":"J Karkhanis","year":"2014","unstructured":"Karkhanis J, et al. Steroid use in acute liver failure. Hepatology. 2014;59:612\u2013621","journal-title":"Hepatology"},{"key":"10714_CR21","doi-asserted-by":"publisher","first-page":"5108781","DOI":"10.1155\/2018\/5108781","volume":"2018","author":"X Zhang","year":"2018","unstructured":"Zhang X, et al. Bacterial infection and predictors of mortality in patients with autoimmune liver disease-associated acute-on-chronic liver failure. Can J Gastroenterol Hepatol. 2018;2018:5108781","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10714_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/hep.30205","volume":"70","author":"L Anand","year":"2019","unstructured":"Anand L, et al. Flare of autoimmune hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy. Hepatology. 2019;70:587\u2013596","journal-title":"Hepatology"},{"key":"10714_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jceh.2020.08.007","volume":"11","author":"S Sharma","year":"2021","unstructured":"Sharma S, et al. Determinants of outcomes in autoimmune hepatitis presenting as acute on chronic liver failure without extrahepatic organ dysfunction upon treatment with steroids. J Clin Exp Hepatol. 2021;11:171\u2013180","journal-title":"J Clin Exp Hepatol"},{"key":"10714_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12876-021-01653-4","volume":"21","author":"L Zheng","year":"2021","unstructured":"Zheng L, et al. Clinical characteristics and treatment outcomes of acute severe autoimmune hepatitis. BMC Gastroenterol. 2021;21:93","journal-title":"BMC Gastroenterol"},{"key":"10714_CR25","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1056\/NEJMra1914900","volume":"382","author":"V Arroyo","year":"2020","unstructured":"Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure. N Engl J Med. 2020;382:2137\u20132145","journal-title":"N Engl J Med"},{"key":"10714_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353\u2013390","journal-title":"Hepatol Int"},{"key":"10714_CR27","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/lt.25451","volume":"25","author":"MN Rahim","year":"2019","unstructured":"Rahim MN, et al. Acute severe autoimmune hepatitis: corticosteroids or liver transplantation? Liver Transpl. 2019;25:946\u2013959","journal-title":"Liver Transpl"},{"key":"10714_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100149","volume":"2","author":"MN Rahim","year":"2020","unstructured":"Rahim MN, Miquel R, Heneghan MA. Approach to the patient with acute severe autoimmune hepatitis. JHEP Rep. 2020;2: 100149","journal-title":"JHEP Rep"},{"key":"10714_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.31065","volume":"72","author":"CL Mack","year":"2020","unstructured":"Mack CL, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases. Hepatology. 2020;72:671\u2013722","journal-title":"Hepatology"},{"key":"10714_CR30","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/lt.21036","volume":"13","author":"P Ichai","year":"2007","unstructured":"Ichai P, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl. 2007;13:996\u20131003","journal-title":"Liver Transpl"},{"key":"10714_CR31","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00535-020-01699-3","volume":"55","author":"K Fujiwara","year":"2020","unstructured":"Fujiwara K, et al. Infectious complications and timing for liver transplantation in autoimmune acute liver failure in Japan: a subanalysis based on nationwide surveys between 2010 and 2015. J Gastroenterol. 2020;55:888\u2013898","journal-title":"J Gastroenterol"},{"key":"10714_CR32","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/hep.30787","volume":"70","author":"D Meher","year":"2019","unstructured":"Meher D, Khatua CR, Singh SP. Letter to the editor: concerns regarding the ACLF research consortium (AARC) study on corticosteroid therapy for autoimmune hepatitis flare causing acute on chronic liver failure. Hepatology. 2019;70:1873","journal-title":"Hepatology"},{"key":"10714_CR33","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/hep.30615","volume":"70","author":"S Habib","year":"2019","unstructured":"Habib S. Letter to editor: flare of autoimmune hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy. Hepatology. 2019;70:754\u2013755","journal-title":"Hepatology"},{"issue":"17","key":"10714_CR34","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s12072-023-10482-4","volume":"2023","author":"S Sharma","year":"2023","unstructured":"Sharma S, et al. Identifying the early predictors of non-response to steroids in patients with flare of autoimmune hepatitis causing acute-on-chronic liver failure. Hepatol Int. 2023;2023(17):989\u2013999","journal-title":"Hepatol Int"},{"key":"10714_CR35","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S0168-8278(94)80251-3","volume":"21","author":"GA Nikias","year":"1994","unstructured":"Nikias GA, Batts KP, Czaja AJ. The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol. 1994;21:866\u2013871","journal-title":"J Hepatol"},{"key":"10714_CR36","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s00535-011-0421-y","volume":"46","author":"M Abe","year":"2011","unstructured":"Abe M, et al. Present status of autoimmune hepatitis in Japan: a nationwide survey. J Gastroenterol. 2011;46:1136\u20131141","journal-title":"J Gastroenterol"},{"key":"10714_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00535-016-1267-0","volume":"52","author":"A Takahashi","year":"2017","unstructured":"Takahashi A, et al. Autoimmune hepatitis in Japan: trends in a nationwide survey. J Gastroenterol. 2017;52:631\u2013640","journal-title":"J Gastroenterol"},{"key":"10714_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.dld.2009.04.009","volume":"42","author":"Y Miyake","year":"2010","unstructured":"Miyake Y, et al. Autoimmune hepatitis with acute presentation in Japan. Dig Liver Dis. 2010;42:51\u201354","journal-title":"Dig Liver Dis"},{"key":"10714_CR39","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41395-018-0160-2","volume":"113","author":"DR Ganger","year":"2018","unstructured":"Ganger DR, et al. Acute liver failure of indeterminate etiology: a comprehensive systematic approach by an expert committee to establish causality. Am J Gastroenterol. 2018;113:1319","journal-title":"Am J Gastroenterol"},{"key":"10714_CR40","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.aohep.2018.11.003","volume":"18","author":"M Mendizabal","year":"2019","unstructured":"Mendizabal M, et al. Liver transplantation in adults with acute liver failure: outcomes from the Argentinean transplant registry. Ann Hepatol. 2019;18:338\u2013344","journal-title":"Ann Hepatol"},{"key":"10714_CR41","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00535-017-1394-2","volume":"53","author":"M Nakao","year":"2018","unstructured":"Nakao M, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53:752\u2013769","journal-title":"J Gastroenterol"},{"key":"10714_CR42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/lt.24347","volume":"22","author":"KR Reddy","year":"2016","unstructured":"Reddy KR, et al. Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States. Liver Transpl. 2016;22:505\u2013515","journal-title":"Liver Transpl"},{"key":"10714_CR43","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/lt.25729","volume":"26","author":"V Liukkonen","year":"2020","unstructured":"Liukkonen V, et al. Role of autoimmunity in patients transplanted for acute liver failure of unknown origin: a clinical and graft biopsy analysis. Liver Transpl. 2020;26:764\u2013773","journal-title":"Liver Transpl"},{"key":"10714_CR44","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jceh.2019.04.050","volume":"9","author":"A Gawande","year":"2019","unstructured":"Gawande A, et al. Acute-on-chronic liver failure: etiology of chronic and acute precipitating factors and their effect on mortality. J Clin Exp Hepatol. 2019;9:699\u2013703","journal-title":"J Clin Exp Hepatol"},{"key":"10714_CR45","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1007\/s00535-021-01834-8","volume":"56","author":"N Nakayama","year":"2021","unstructured":"Nakayama N, et al. Nationwide survey for patients with acute-on-chronic liver failure occurring between 2017 and 2019 and diagnosed according to proposed Japanese criteria. J Gastroenterol. 2021;56:1092\u20131106","journal-title":"J Gastroenterol"},{"key":"10714_CR46","doi-asserted-by":"publisher","first-page":"6470847","DOI":"10.1155\/2022\/6470847","volume":"2022","author":"\u00c1 Urz\u00faa","year":"2022","unstructured":"Urz\u00faa \u00c1, et al. Autoimmune hepatitis with acute presentation: clinical, biochemical, and histological features of 126 patients. Can J Gastroenterol Hepatol. 2022;2022:6470847","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10714_CR47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1872-034X.2011.00892.x","volume":"42","author":"S Yasui","year":"2012","unstructured":"Yasui S, et al. Importance of computed tomography imaging features for the diagnosis of autoimmune acute liver failure. Hepatol Res. 2012;42:42\u201350","journal-title":"Hepatol Res"},{"key":"10714_CR48","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/jclinpath-2016-204271","volume":"70","author":"H Nguyen Canh","year":"2017","unstructured":"Nguyen Canh H, et al. Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients. J Clin Pathol. 2017;70:961\u2013969","journal-title":"J Clin Pathol"},{"key":"10714_CR49","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/hep.24080","volume":"53","author":"RT Stravitz","year":"2011","unstructured":"Stravitz RT, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology. 2011;53:517\u2013526","journal-title":"Hepatology"},{"key":"10714_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u2013176","journal-title":"Hepatology"},{"key":"10714_CR51","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929\u2013928","journal-title":"J Hepatol"},{"key":"10714_CR52","first-page":"360","volume":"57","author":"TL Huo","year":"1996","unstructured":"Huo TL, et al. Autoimmune hepatitis in an area endemic for hepatitis B virus infection: a report of three cases. Zhonghua Yi Xue Za Zhi (Taipei). 1996;57:360\u2013364","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"10714_CR53","first-page":"512","volume":"61","author":"S Khawaja","year":"2011","unstructured":"Khawaja S, Abdul Muqtadir K, Taj Y. Warm autoimmune haemolytic anaemia and autoimmune hepatitis in an asymptomatic carrier of hepatitis B virus. J Pak Med Assoc. 2011;61:512\u2013515","journal-title":"J Pak Med Assoc"},{"key":"10714_CR54","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/00042737-200608000-00021","volume":"18","author":"V Nobili","year":"2006","unstructured":"Nobili V, et al. Co-occurrence of chronic hepatitis B virus infection and autoimmune hepatitis in a young Senegalese girl. Eur J Gastroenterol Hepatol. 2006;18:927\u2013929","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10714_CR55","first-page":"2139607","volume":"2018","author":"V Sostre","year":"2018","unstructured":"Sostre V, et al. A case of acute autoimmune hepatitis superimposed on chronic hepatitis B infection. Case Rep Gastrointest Med. 2018;2018:2139607","journal-title":"Case Rep Gastrointest Med"},{"key":"10714_CR56","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1055\/s-0034-1375959","volume":"34","author":"AS deLemos","year":"2014","unstructured":"deLemos AS, et al. Drug-induced liver injury with autoimmune features. Semin Liver Dis. 2014;34:194\u2013204","journal-title":"Semin Liver Dis"},{"key":"10714_CR57","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1159\/000480139","volume":"35","author":"A Tsutsui","year":"2017","unstructured":"Tsutsui A, et al. Clinicopathological study of autoimmune hepatitis cases that were difficult to differentiate from drug-induced liver injury. Dig Dis. 2017;35:506\u2013514","journal-title":"Dig Dis"},{"key":"10714_CR58","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","volume":"63","author":"EASL Clinical Practice Guidelines","year":"2015","unstructured":"EASL Clinical Practice Guidelines. Autoimmune hepatitis. J Hepatol. 2015;63:971\u20131004","journal-title":"J Hepatol"},{"key":"10714_CR59","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jhep.2016.03.023","volume":"65","author":"R Moenne-Loccoz","year":"2016","unstructured":"Moenne-Loccoz R, et al. Usefulness of corticosteroids as first-line therapy in patients with acute severe autoimmune hepatitis. J Hepatol. 2016;65:444\u2013446","journal-title":"J Hepatol"},{"key":"10714_CR60","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jhep.2021.08.013","volume":"76","author":"S Lin","year":"2022","unstructured":"Lin S, et al. Validation of the SURFASA score to define steroid responsiveness in patients with acute autoimmune hepatitis. J Hepatol. 2022;76:485\u2013487","journal-title":"J Hepatol"},{"key":"10714_CR61","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/qjmed\/hch072","volume":"97","author":"R Ferrari","year":"2004","unstructured":"Ferrari R, et al. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the \u201cacute\u201d type. QJM. 2004;97:407\u2013412","journal-title":"QJM"},{"key":"10714_CR62","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/j.1440-1746.2008.05365.x","volume":"23","author":"S Seo","year":"2008","unstructured":"Seo S, et al. Favorable outcomes of autoimmune hepatitis in a community clinic setting. J Gastroenterol Hepatol. 2008;23:1410\u20131414","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10714-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10714-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10714-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T20:27:07Z","timestamp":1728419227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10714-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,11]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10714"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10714-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,11]]},"assertion":[{"value":"24 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}